An expert committee of India's drug regulator has recommended emergency use authorisation (EUA) for Merck's Covid-19 pill molnupiravir, and Serum Institute of India's Covovax and Biological E's corbevax vaccines, the Economic Times reported.
The recommendations by the subject expert committee have been sent to the Drugs Controller General of India, which will soon decide on their approval, according to the report.
Data presented for Covovax, the Indian version of Novavax Inc's Covid-19 vaccine, was satisfactory, the report said.
